Related Experiment Videos

Rolandic encephalopathy and epilepsia partialis continua following bone marrow transplant

N L Antunes1, F Boulad, V Prasad

  • 1Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Bone Marrow Transplantation
|November 18, 2000
PubMed

Insights

Epilepsia partialis continua (EPC), a prolonged focal myoclonus, can occur after bone marrow transplants. An unidentified infection may cause this rare encephalitis in immunosuppressed patients, responding to antiviral treatment.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Epilepsia partialis continua (EPC) is characterized by persistent focal myoclonus, often treatment-resistant.
  • EPC in children is commonly associated with Rasmussen encephalitis, a chronic encephalitis of unknown cause.
  • Rasmussen encephalitis typically affects one hemisphere of the brain.

Observation:

  • A child developed bilateral EPC five months post-bone marrow transplant.
  • Neuroimaging revealed signal abnormalities in bilateral sensory-motor areas.
  • The patient was immunosuppressed following the transplant.

Findings:

  • Extensive etiological investigations were inconclusive.
  • Treatment with a broad-spectrum antiviral agent led to the resolution of EPC.
  • This suggests an infectious etiology previously unrecognized in this context.

Implications:

  • An unidentified infectious agent might cause encephalitis affecting the motor cortex in immunosuppressed individuals.
  • This case expands the known spectrum of post-transplant neurological complications.
  • Further research is needed to identify the causative agent and understand its pathogenesis.

Related Concept Videos